8 Years Without Relapse After Small Cell Lung Cancer Treatment

Patient Profile:
65 years old
Diagnosed in September 2016 with small cell lung cancer in the left lung, with mediastinal and pleural metastases.

Treatment Approach:
He received combined chemoradiotherapy alongside cell therapy, aimed at enhancing treatment effectiveness and improving immune response.
Following initial treatment, he began annual immune cell maintenance therapy, a preventive approach designed to support long-term remission.

Outcome:
Now, 8 years later, He shows no signs of recurrence or metastasis. Regular follow-up exams confirm continued remission. He has returned to a normal, active life.

This case highlights the potential of integrating immune cell therapy into standard cancer treatments to reduce relapse risk and support long-term recovery.